Objective: To determine the predictive role of rst trimester maternal serum ELABELA (ELA) levels in late-onset preeclampsia (PE). Study Design: Comparative descriptive study. Place and Duration of Study: Department of Obstetrics and Gynecology, Bursa Yüksek 0htisas Training and Research Hospital, Bursa, Turkey between January and September 2019. Methodology: A total of 600 pregnant women, whose maternal serum samples were collected through the rst trimester screening test, were recruited. Twenty-three patients with late-onset PE group and 47 without PE group were included. All participants in whom maternal serum samples were collected between 1t1h and 14th weeks of pregnancy were followed until delivery. Results: Median ELA level was 654.53 [217.67-870.20] pg/mL in the PE group and 645.80 [367.25-1833.17] pg/mL in the control group, indicating no signi cant di erence between the groups (p=0.408). There was a statistically signi cant di erence between the two groups in terms of frequency of history of hypertension, intrauterine growth restriction (IUGR) and acute fetal distress (AFD), (p=0.003, p=0.016, and p=0.005, respectively). Three patients had preterm delivery in the PE group which was non-signi cant, while seven patients had gestational diabetes mellitus in PE group that was signi cantly higher compared to controls (p<0.001). Conclusion: Only ELA level in the rst trimester of pregnancy may not be of much value in predicting late-onset PE.